Beating Bribery and Corruption in the Life Sciences: The Big Picture
Paul Vincke, President of the European Healthcare Fraud and Corruption Network, and a civil servant at the Ministry of Health in Belgium, outlines recent developments in anti-corruption and bribery legislation in the pharmaceuticals industry.
The UK Bribery Bill: Issued in April 2010 is due to come into force in April 2011. As this is one of the biggest developments in this area for years, we ask Vincke how he interprets the delays in enforcing this legislation, what the implications...
To continue reading this story get free access